Dr. Jeff Geschwind earned his Medical Degree from Boston University School of Medicine, completed his residency training in Diagnostic Radiology at the University of California at San Francisco as a Resident-Scholar sponsored by the National Institutes of Health (NIH) and carried out his fellowship training in Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine.  He is the former Director of the Division of Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine and Chairman of Radiology and Biomedical Imaging at Yale School of Medicine.

Dr. Geschwind has published nearly 300 scientific manuscripts (Google Scholar H-Index 75), wrote the first textbook dedicated to Interventional Oncology, co-edited the textbook of reference in Interventional Radiology, namely, Abram’s Angiography, and was the lead or co-investigator on more than 50 clinical trials testing innovative treatments for patients with liver cancer. He is recognized internationally as an expert and key opinion leader in liver cancer, more generally the new field of Interventional Oncology.

Dr. Geschwind has received numerous national and international awards throughout his career, including, the Annual Memorial Award from the Association of University Radiologists, the Alexander Margulis Award for Excellence in Research, the Society of Interventional Radiology Gary Becker Young Investigator Award, the American Society of Clinical Oncology Merit Award, the American Roentgen Ray Society Fellowship Award, the Boston University School of Medicine and the University of California San Francisco Department of Radiology Alumni Award, the Ernest Ring Academic Development Program from the Society of Interventional Radiology and the Wilhelm Conrad Roentgen Honorary Award from the European Society of Radiology. Most recently, he was recognized by Marquis Who’s Who organization for his scientific accomplishments during his career and awarded the Albert Nelson Marquis Lifetime Achievement Award. In 2012, he was inducted into the Academy of Radiology Research from the Radiology Society of North America, the highest recognition for radiologists.

CORE COMPETENCIES

• Participating on the editorial board of scientific journals, including “Radiology, Cardiovascular and Interventional Radiology, Journal of Vascular and Interventional Radiology,” “Anticancer Research,” “Diagnostics” and “Gastroenterology Insights”
• Providing journal reviews (e.g. Lancet, Cancer Research, Hepatology and Journal of Clinical Oncology)
• Visiting professorships, lectures and keynote speeches including named lectures (among others): NIH John Doppman Memorial Lecture for Imaging Sciences, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, the University of Michigan, Georgetown University, Brown University, Yonsei University, Seoul National University, Malaysia Cancer Center, and the Chinese University of Hong Kong
• Recognized as a Top Doctor by US News and World Report
• Diplomate of the American Board of Radiology since 1998

RECENT PROJECTS

• Cryoablation for breast cancer
• Endobronchial therapy for lung cancer
• Intraarterial therapy using radioactive microspheres for liver cancer
• Noninvasive ultrasound-guided therapy for liver and kidney cancer